CCM
AGN

Catapult Capital Management’s Allergan plc AGN Stock Holding History

Catapult Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-4,000
Closed -$892K – 255
2014
Q2 		$892K Buy
+4,000
New +$828K 0.1% 164

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Catapult Capital Management's AGN Position: Q3 2015 in Review

Catapult Capital Management increased its Allergan plc (AGN) stake by 325% in Q3 2015, buying an estimated $9.98M and bringing the position to 42,500 shares worth $11.6M. The position accounts for 4.37% of the portfolio, ranked #1.

Catapult Capital Management first reported a position in AGN in Q2 2013 and has held it in 9 quarters since. The position peaked at $16.4M in Q4 2013. 1,056 funds tracked by Wall St. Rank hold AGN as of Q3 2015.

  • Catapult Capital Management held 42,500 shares of Allergan plc worth $11.6M as of Q3 2015.
  • Catapult Capital Management bought 32,500 Allergan plc shares in Q3 2015, an estimated $9.98M.
  • Allergan plc made up 4.37% of Catapult Capital Management's portfolio in Q3 2015, its #1 holding.
  • Catapult Capital Management first reported a position in Allergan plc in Q2 2013 and has held it in 9 quarters since.
  • Catapult Capital Management's Allergan plc position peaked at $16.4M in Q4 2013.
  • 1,056 funds tracked by Wall St. Rank held Allergan plc as of Q3 2015.

Based on Catapult Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.